Contineum与强生合作的多发性硬化症药物在二期试验中未能改善视力
Contineum's J&J-partnered MS drug fails to improve vision in phase 2
#Contineum Therapeutics’#receptor antagonist#multiple sclerosis#drug fails#common form
生命科学资讯
生物技术与制药领域的最新动态
FDA宣布增聘逾千名员工并启动审评流程新沟通计划
FDA says it's hiring more than 1,000 new staffers, launches new comms program for review process
#review process#pilot communication#comms program#communication program#FDA
葛兰素史克旗下Tesaro与AnaptysBio因Jemperli协议对簿公堂
GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement
#GSK Tesaro#Jemperli agreement#GSK subsidiary#subsidiary Tesaro#life span
Nurix启动主要BTK降解剂关键试验之际裁员
Nurix trims workforce as pivotal trial for lead BTK degrader kicks off
#Nurix Therapeutics#Nurix trims#BTK degrader#cancer asset#lead BTK
罗氏签署超2亿美元许可协议，引进Freenome癌症筛查血液检测技术
Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests
#Roche inks#licensing pact#million equity#Freenome cancer#blood tests
吉列德突然与总法律顾问分道扬镳
Chutes & Ladders—Gilead abruptly parts ways with general counsel
#Deborah Telman#filing Nov.#Gilead abruptly#general counsel#affairs Deborah
CDC指示研究人员年底前终止所有猴子研究：《科学》
CDC instructs researchers to end all monkey studies by year-end: Science
#Science reported#CDC instructs#instructs researchers#instructing scientists#research involving
Versant旗下Dayra公司携5000万美元与Biogen达成合作，致力于口服大环肽药物研发
Versant's Dayra dawns with $50M Biogen pact, oral macrocyclic peptide mission
#Dayra Therapeutics#Versant Ventures#oral macrocyclic#macrocyclic peptide#Versant Dayra
强生公司50亿美元阿尔茨海默病希望破灭，抗tau抗体posdinemab二期试验失败
J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2
#Alzheimer hope#anti-tau antibody#antibody posdinemab#hope fades#disease drug
艾伯特将更换部分FreeStyle Libre 3连续血糖监测仪，因读数错误及死亡报告
Abbott to replace certain FreeStyle Libre 3 CGMs after incorrect readings and death reports
#FreeStyle Libre#million FreeStyle#death reports#Libre#incorrect readings
吉利德与瑞典生物技术公司达成价值4亿美元的生物技术交易，涉及其TREX1癌症项目。
Gilead hatches $400M biobucks deal for Swedish biotech’s TREX1 cancer program
#Sprint Bioscience#cancer program#Swedish biotech#Gilead hatches#million upfront
诺和诺德股价因阿尔茨海默症药物semaglutide两项试验失败而暴跌8%
Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease
#Alzheimer disease#Novo Nordisk#trial misses#Novo shares#Alzheimer
"人们正在适应它"：全球不确定性未能削弱杰富瑞会议的乐观气氛
'People are getting used to it': Global uncertainties can't dampen upbeat Jefferies conference
#Jefferies conference#Global uncertainties#upbeat Jefferies#cautious optimism#dampen upbeat
拜耳药物asundexian在三期试验中降低中风风险，重燃FXIa类药物希望
Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class
#Bayer asundexian#reviving hopes#FXIa class#significantly reduced#potentially blockbuster
Sarepta公布DM1资产积极安全性更新，Arrowhead斩获2亿美元里程碑款项
Sarepta shares positive safety update on DM1 asset as Arrowhead snares $200M milestone
#Sarepta-licensed RNA#RNA medicine#Sarepta shares#enrollment target#Arrowhead snares
Solventum将以高达8.5亿美元收购Acera Surgical，并回购10亿美元股票
Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock
#Acera Surgical#buy Acera#specialist Acera#years ago#major acquisition
强生医疗科技在爱尔兰加强中风研发项目
J&J MedTech bolsters stroke R&D programs in Ireland
#MedTech bolsters#bolsters stroke#innovation center#completed earlier#hreflang